|
 |
| BVF - Biovail Corp. | Week Ended: 3/10/01 |
|
| Price |
37.70 |
P/E Ratio |
N/A |
52 Week High |
47.40 |
| Last Week |
- 2.17 |
Earnings Date |
2/28/01 |
52 Week Low |
19.13 |
| Picked At |
46.15 |
Date Picked |
2/12/01 |
Sector |
Healthcare |
| Activity |
| Current |
37.70 |
Open |
37.61 |
Change |
0.10 |
| Low |
37.61 |
High |
39.25 |
Volume |
1,564,800 |
ZACKS | NEWS | PROFILE | HISTORICAL PRICES | OPTIONS | D-CHART |
| Company Description Biovail Corporation is a fully integrated pharmaceutical company specializing in the development of drugs utilizing advanced controlled-release, rapid dissolve, enhanced absorption and taste masking technologies. The Company generates its revenues from developing and licensing oral controlled-release products using its proprietary drug delivery technologies; manufacturing such products for sale to licensees and wholesalers; direct marketing of proprietary and in-licensed products in Canada, and providing pharmaceutical contract research services to Intelligent Polymers Limited and other third parties.
|
| Play Description February 12, 2001
Biovail Corporation develops and manufactures drugs utilizing advanced oral controlled-release, rapid dissolve, enhanced absorption and taste masking technologies. The Company currently has developed 15 products that are sold under license in over 55 countries. BVF ran into some profit taking in November after hitting an all-time high of $45.38 on November 8th. The stock then put in a triple-bottom over the course of two months. Now the stock has regained its momentum and on Monday, the stock broke out to an all-time high of $46.15 on volume of 956,000 shares. This was the move we were looking for so we are adding them to our current plays list. Going forward, support is the 10-dma at $43.76 with additional support at $42.90, Monday’s intra-day low. Resistance could show up in the $47-$48 range with heavier resistance at $50. Traders may consider staring new plays on a bounce off of $43.76 or a break out above $47 on volume greater than 800,000 shares by noon. We plan to set stops at $41.50 as downside protection.
Picked on February 12th @ $46.15
Change since picked +0.00
Stop Loss @ $41.50
|
| Update March 4, 2001
Biovail Corporation continued to slide on Friday following Thursday morning’s earnings release. Shares of BVF traded to an intra-day low of $40.95 on heavy volume of 3.78 million shares. We were stopped out at $41.50 so we are dropping BVF from our Current Plays List.
Picked on February 12th @ $46.15
Profit/Loss = –4.65 (-10%) (Stopped out Friday @ $41.50)
Best Profit = +1.59 (+3%)
|
|
|
|
